Pulmozyme

In the US, Pulmozyme (dornase alfa systemic) is a member of the drug class miscellaneous respiratory agents and is used to treat Cystic Fibrosis.

US matches:

UK matches:

Ingredient matches for Pulmozyme

Deoxyribonuclease I

Deoxyribonuclease I Dornase alfa (a derivative of Deoxyribonuclease I) is reported as an ingredient of Pulmozyme in the following countries:

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Bosnia & Herzegowina
  • Brazil
  • Bulgaria
  • Canada
  • Colombia
  • Croatia (Hrvatska)
  • Cyprus
  • Czech Republic
  • Denmark
  • Ecuador
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Mexico
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Poland
  • Romania
  • Russian Federation
  • Serbia
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • United States
  • Uruguay

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web2)